Home » Newsletters » BioWorld Science

BioWorld Science

April 27, 2001

View Archived Issues

Idec reports status of select products

Biogen makes considerable pipeline progress during Q1 2001

CPMP, FDA panel recommend approval of Ketek for community-acquired RTIs

Menjugate receives expedited approval in Canada

Medarex and Northwest Biotherapeutics enter cancer therapy alliance

Exelixis to acquire Artemis

Photogen products advance in clinical trials

Inhibitors of STAT3 activation identified using new high-throughput assay

Potential small-molecule cancer therapeutic designed at Agouron to be selective for VEGF RTK

MMP-1-sparing MMP inhibitor demonstrates activity against lung, prostate and breast cancers

Company Profile: Newron Pharmaceuticals

Health Canada seeks more information to support Hemolink NDS

Titanium-based antiviral compound presented at Antiviral Research conference

Preclinical and clinical profile of Neotrofin reviewed by NeoTherapeutics at AD/PD meeting

Incara's catalytic antioxidants show promise in preclinical studies in the therapy of cancer

Idun licenses SMAC gene from UT Southwestern Medical Center

Titan and Novartis expand Zomaril agreement to include Japan

Beta-sheet-forming peptide designed as novel antiangiogenic agent

Icos initiates phase III trial of Pafase for treatment of severe sepsis

Ovarian cancer vaccines prepared at Corixa

Novel calpain protease discovered by Millennium team

New adenosine A2A antagonists and use described by Roche

Aventis discloses series of HSL inhibitors

Potential atypical antipsychotic agents in the Egis pipeline

New series of selective ERalpha ligands designed at Akzo Nobel

Indena focuses on modulators of MDR

Forbes Medi-Tech halts CardioRex development; steps up development of second-generation compound

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...